Validation of hepatitis B virus–related hepatocellular carcinoma prediction models in the era of antiviral therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|6|1757-1766

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.6, 2015-12, pp. : 1757-1766

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: pre‐ and post‐operative anti‐viral therapy is important for patients with hepatitis B virus‐related hepatocellular carcinoma

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 789-790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum to: Effects of antiviral therapy on long‐term outcome after liver resection for hepatitis B virus‐related hepatocellular carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 697-697

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of antiviral therapy on long‐term outcome after liver resection for hepatitis B virus‐related hepatocellular carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 685-696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral therapy in the improvement of survival of patients with hepatitis B virus‐related hepatocellular carcinoma treated with sorafenib

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 6, 2015-06 ,pp. : 1032-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: pre‐ and post‐operative anti‐viral therapy is important for patients with hepatitis B virus‐related hepatocellular carcinoma – authors’ reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 8, 2015-04 ,pp. : 790-790

John Wiley & Sons Inc

Access to resources Recommend Favorite